Workflow
青岛中程索赔案持续推进
Xin Lang Cai Jing·2025-11-03 08:03

Core Points - Qingdao Zhongcheng (300208) has received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) for false statements in its financial reports [1][2] - The law firm Shanghai Jiucheng, represented by lawyer Xu Feng, is currently accepting claims from investors who suffered losses due to these violations [1][2] Summary by Sections Financial Misstatements - Qingdao Zhongcheng's annual reports from 2017 to 2022 contained significant false records, including: - 2017: Overstated revenue by 1,403.22 million, 92.18% of reported revenue; overstated profit by 552.77 million, 136.17% of reported profit [1] - 2018: Overstated revenue by 467.89 million, 36.00% of reported revenue; overstated profit by 217.76 million, 94.92% of reported profit [1] - 2019: Understated revenue by 672.44 million, 88.83% of reported revenue; understated profit by 285.38 million, 78.36% of reported profit [1] - 2020: Overstated intangible assets by 300.23 million, 6.53% of total assets; understated revenue by 343.08 million, 118.51% of reported revenue; understated profit by 281.80 million, 56.22% of reported profit [1] - 2021: Overstated intangible assets by 309.70 million, 7.37% of total assets; understated revenue by 0.73 million, 0.46% of reported revenue; overstated profit by 0.50 million, 5.83% of reported profit [1] - 2022: Overstated intangible assets by 309.70 million, 7.42% of total assets [1] Legal Proceedings - Investors who purchased Qingdao Zhongcheng stock between April 25, 2018, and April 29, 2024, may initiate claims for compensation [2] - The law firm is also handling claims for investors of Haofeng Technology (300419), which has also faced penalties from the CSRC for similar violations [2][3] Haofeng Technology Violations - Haofeng Technology was found to have inflated its 2020 revenue by 73.13 million, 11.43% of its annual revenue, due to misreporting related to financing activities [2][3] - Investors who bought Haofeng Technology stock between April 26, 2021, and December 27, 2023, are eligible to file claims [3]